1,25(OH)2D3 induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats

Calcified Tissue International

Volumn 94, Issue 5, 2014, Pages 531-543

  Ng, Adeline H ^a   Frick, Kevin K ^b   Krieger, Nancy S ^b   Asplin, John R ^c   Cohen Mcfarlane, Madison ^a   Culbertson, Christopher D ^b   Kyker Snowman, Kelly ^b   Grynpas, Marc D ^a   Bushinsky, David A ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c LithoLink Corporation   (United States)

Author keywords

Bone quality; Calcium; Reabsorption; Vitamin D

Indexed keywords

1,25(OH) 2 D 3; CALCIUM ION; UNCLASSIFIED DRUG; VITAMIN D; CALCITRIOL; CALCITRIOL RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERALIZATION; BONE STRENGTH; BONE STRUCTURE; BONE TURNOVER; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; GENETIC HYPERCALCIURIC STONE; HYPERCALCIURIA; LOW DRUG DOSE; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; TRABECULAR BONE; UCA; ANIMAL; BONE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MUTANT RAT STRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; DISEASE MODELS, ANIMAL; HYPERCALCIURIA; MALE; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL;

EID: 84898910186     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-014-9838-7     Document Type: Article

References (50)

1. Bushinsky DA, Coe FL, Moe OW (2012) Nephrolithiasis. In: Brenner BM (ed) The kidney. WB Saunders, Philadelphia, pp 1455-1507
2. Moe OW, Bonny O (2005) Genetic hypercalciuria. J Am Soc Nephrol 16:729-745
3. Stechman MJ, Loh NY, Thakker RV (2007) Genetics of hypercalciuric nephrolithiasis: renal stone disease. Ann N Y Acad Sci 1116:461-484
4. Monico CG, Milliner DS (2012) Genetic determinants of urolithiasis. Nat Rev Nephrol 8:151-162
5. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975-987
6. Bushinsky DA, Favus MJ (1988) Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 82:1585-1591
7. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL (1995) Stone formation in genetic hypercalciuric rats. Kidney Int 48:1705-1713
8. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA (2004) Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 65:154-161
9. Grynpas M, Waldman S, Holmyard D, Bushinsky DA (2009) Genetic hypercalciuric stone-forming rats have a primary decrease in bone mineral density and strength. J Bone Miner Res 24:1420-1426
10. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA (1993) Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43:189-196
11. 3 in bone from genetic hypercalciuric rats. Am J Physiol Cell Physiol 271:C130-C135
12. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ (1993) Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 91:661-667
13. Tsuruoka S, Bushinsky DA, Schwartz GJ (1997) Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51:1540-1547
14. Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SPY, Grynpas M (2011) Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats. J Bone Miner Res 26:1904-1912
15. Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ (2010) Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of snail. J Bone Miner Res 25:830-840
16. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA (2009) Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20:1246-1253
17. Perry GML, Nehrke KW, Bushinsky DA, Reid R, Lewandowski KL, Hueber P, Scheinman SJ (2012) Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus). Genetics 191:1003-1013
18. Bushinsky DA, Michalenka AC, Strutz KL, Donahue S, Asplin JR (2007) Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 73:423-429
19. Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, Scheinman SJ (2006) Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 17:1292-1304
20. Bushinsky DA, LaPlante K, Asplin JR (2006) Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 69:1586-1592
21. 3 in genetic hypercalciuric stone forming rats. J Am Soc Nephrol 16:1300-1308
22. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447-454
23. Bushinsky DA, Asplin JR (2005) Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16:417-424
24. Hoopes RR, Reid R, Sen S, Szpirer C, Dixon P, Pannet A, Thakker RV, Bushinsky DA, Scheinman SJ (2003) Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol 14:1844-1850
25. Bushinsky DA, Grynpas MD, Asplin JR (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59:1415-1423
26. Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550-560
27. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD (1999) Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55:602-612
28. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS (1999) Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55:234-243
29. 3: a new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101:2223-2232
30. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL (1997) Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51:640-645
31. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL (1994) Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45:58-65
32. 3 in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol 304:F718-F726
33. Frick KK, Bushinsky DA (2003) Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14:1082-1095
34. Adams ND, Gray RW, Lemann JJ (1982) Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21:90-97
35. 3 concentrations in healthy men. Kidney Int 24:555-560
36. Hoenderop JGJ, Nilius B, Bindels RJM (2005) Calcium absorption across epithelia. Physiol Rev 85:373-422
37. 3 and PTH. Am J Physiol Renal Physiol 261:F799-F807
38. 3 in calcium stone formers with idiopathic hypercalciuria. Contrib Nephrol 58:137-142
39. 2D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N Engl J Med 302:421-426
40. Insogna KL, Broadus AE, Dryer BE, Ellison AF, Gertner JM (1985) Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61:490-495
41. 3) in patients with idiopathic hypercalciuria (IH). Clin Res 23:423A
42. 3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24:307-313
43. Favus MJ, Karnauskas AJ, Parks JH, Coe FL (2004) Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89:4937-4943
44. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468-1486
45. Parfitt AM, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Reker RR (1987) Bone histomorphometry nomenclature, symbols and units. Bone Miner Res 2:595-610
46. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2-17
47. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, Lafage-Proust M-H, Dresselaers T, Feng JQ, Bonewald LF, Meyer MB, Pike JW, Bouillon R, Carmeliet G (2012) Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 122:1803-1815
48. Krieger NS, Hefley TJ (1989) Differential effects of parathyroid hormone on protein phosphorylation in two osteoblast-like cell populations isolated from neonatal mouse calvaria. Calcif Tissue Int 44:192-199
49. Baldock PA, Thomas GP, Hodge JM, Baker SU, Dressel U, O'Loughlin PD, Nicholson GC, Briffa KH, Eisman JA, Gardiner EM (2006) Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 21:1618-1626
50. Parfitt AM (1990) Osteomalacia and related disorders. In: Aviolo L, Krane S (eds) Metabolic bone disease. Saunders, Philadelphia, pp 329-396